Mitochondrial dysfunction and senescence accompany glioblastoma cell death triggered by a putative metabolic inhibitor
{{output}}
Glioblastoma (GBM) is a fatal cancer with a dismal prognosis and a dire need for novel chemotherapeutics. Metabolic reprogramming is an established hallmark of cancer. In our previous study on GBM, we aimed at targeting the metabolic reprogramming of cancer by... ...
